Group 1 - Nebius Group plans to raise $3 billion to support growth in its artificial intelligence cloud business following a $17.4 billion deal with Microsoft [1][3] - The financing structure includes a $2 billion private offering of convertible senior notes and a $1 billion underwritten public offering of class A shares [1][2] - Goldman Sachs is the lead book-running manager for the public offering, with Morgan Stanley, BofA Securities, and Citigroup as additional managers [2] Group 2 - Nebius will utilize the raised funds to finance growth initiatives, including acquiring additional compute power and hardware, securing land plots, and expanding its data center footprint [2] - The recent deal with Microsoft involves providing GPU infrastructure capacity over a five-year term, potentially increasing the total contract value to approximately $19.4 billion [3] - Following the Microsoft deal, Nebius's Nasdaq-listed shares surged over 49% to a record high, marking a 245% increase year-to-date, although they experienced a 5.6% decline in pre-market trading [3] Group 3 - Nebius originated from a deal to split the assets of the Russian tech company Yandex [4] - There has been a significant rise in global demand for data center capacity, driven by the adoption of new technologies and the emergence of generative artificial intelligence [4]

Core Viewpoint - Smithfield Foods, a subsidiary of WH Group, is conducting a secondary offering of 19,531,698 shares at a price of $23.25 per share, with the offering expected to close on September 8, 2025, subject to customary closing conditions [1] Group 1 - The shares are being sold by SFDS UK Holdings Limited, an indirect wholly-owned subsidiary of the company [1] - SFDS UK has granted underwriters a 30-day option to purchase up to 2,929,754 additional shares at the public offering price, less underwriting discounts and commissions [1] - Smithfield Foods will not sell any shares in the offering and will not receive any proceeds from the sale of shares by SFDS UK [1] Group 2 - Morgan Stanley, BofA Securities, and Barclays are acting as joint book-running managers for the offering [1] - Goldman Sachs & Co. LLC, Citigroup, and BNP Paribas are serving as co-managers for the offering [1]

Group 1 - Smithfield Foods, Inc. announced a secondary public offering of 19,531,698 shares at a price of $23.25 per share, with an additional option for underwriters to purchase up to 2,929,754 shares [1] - The offering is expected to close on September 8, 2025, subject to customary closing conditions [1] - The company will not receive any proceeds from the sale of shares as it is solely conducted by the principal shareholder, SFDS UK Holdings Limited [1] Group 2 - Morgan Stanley, BofA Securities, and Barclays are acting as joint lead book-running managers for the offering, with Goldman Sachs, Citigroup, and BNP Paribas as joint book-running managers [2] - A registration statement for the offering has been filed and declared effective by the U.S. Securities and Exchange Commission [3] Group 3 - Smithfield Foods is recognized as an industry leader in value-added packaged meats and fresh pork, with a diverse brand portfolio and strong relationships with U.S. farmers and customers [6]

CNBC and streaming on CNBC plus. >> Welcome back to The Exchange. We're seeing a big divergence in the consumer trade today.Discretionary stocks are the best performers while staples is the only sector in the red after Powell paved the way for a September rate cut. My next guest expects that divide to remain. Joining me now is Savita Subramanian, head of U.S. equity and quantitative strategy of B of a securities.And Savita, it's great to have you on. This divergence we're seeing in the consumer and specific ...

Core Viewpoint - Solventum Corporation announced a secondary offering of 8,800,000 shares of its common stock, expected to generate approximately $648 million in gross proceeds for 3M Company, the selling shareholder, with the offering closing around August 15, 2025 [1]. Group 1: Offering Details - The offering consists of shares sold entirely by the selling shareholder, 3M Company, and Solventum will not receive any proceeds from this offering [1]. - Goldman Sachs & Co. LLC and BofA Securities are acting as underwriters for the offering [2]. - The shares are being offered under the Company's shelf registration statement on Form S-3, which became effective upon filing with the SEC on August 13, 2025 [3]. Group 2: Regulatory Information - The offering is made only by means of a preliminary prospectus supplement filed with the SEC, and interested parties can access these documents for more information [3]. - The press release clarifies that it does not constitute an offer to sell or solicit an offer to buy the securities in any jurisdiction where such actions would be unlawful [4]. Group 3: Company Overview - Solventum aims to enhance healthcare through innovative solutions at the intersection of health, material, and data science, focusing on improving patient outcomes and empowering healthcare professionals [7].

Core Viewpoint - Ball Corporation has initiated a public offering of $750 million in Senior Notes due 2033, with the final terms dependent on market conditions [1] Group 1: Offering Details - The offering consists of $750 million aggregate principal amount of Senior Notes due 2033 [1] - The exact amount, terms, and timing of the offering will be influenced by market conditions and other factors [1] Group 2: Use of Proceeds - Ball plans to use the net proceeds for general corporate purposes, which may include refinancing or repaying debt [2] - A portion of the net proceeds will be used to repay outstanding borrowings under its U.S. dollar and multi-currency revolving credit facilities [2] Group 3: Management and Coordination - BofA Securities, Goldman Sachs & Co. LLC, Citigroup Global Markets Inc., and Morgan Stanley & Co. LLC are acting as global coordinators and joint book-running managers for the offering [3] Group 4: Company Overview - Ball Corporation provides innovative and sustainable aluminum packaging solutions for various sectors, employing 16,000 people globally [6] - The company reported net sales of $11.80 billion for 2024, excluding its divested aerospace business [6]

Group 1 - The conference call is regarding Kosmos Energy's Second Quarter 2025 earnings release [2][3] - Key participants in the call include Andrew G. Inglis (Chairman & CEO), Jamie Buckland (VP of Investor Relations), and Neal D. Shah (CFO) [1][3] - The call will include forward-looking statements about the company's estimates, plans, and expectations [4] Group 2 - The earnings release and accompanying slide presentation are available on the company's Investors page [3] - The call is being recorded for future reference [2] - The company emphasizes the potential for actual results to differ materially from forward-looking statements due to various factors [4]

Core Viewpoint - Brixmor Property Group Inc. held its Q2 2025 earnings call, discussing financial performance and strategic initiatives for the upcoming period [1][2]. Group 1: Financial Performance - The company reported its earnings for the second quarter of 2025, highlighting key financial metrics and performance indicators [3]. - Specific figures regarding revenue, net income, and other financial metrics were discussed, although exact numbers were not provided in the excerpts [1][3]. Group 2: Leadership and Management - The call featured key executives including CEO Jim Taylor, President Brian Finnegan, and CFO Steve Gallagher, who provided insights into the company's operations and future outlook [3]. - The presence of various analysts from leading financial institutions indicates strong interest in the company's performance and strategic direction [1][2].

Core Viewpoint - Advanced Micro Devices (AMD) has received a positive endorsement from BofA Securities, maintaining a 'Buy' rating and raising its price target from $175 to $200, indicating a potential increase of about 15% from its last closing price of $173 [1][4]. Group 1: Price Target and Stock Performance - The new price target of $200 represents a 15% increase from AMD's last closing price of $173 [1]. - AMD's stock has rallied 11% over the past week and ended the previous session up over 4% [1]. Group 2: Earnings Expectations and Revenue Projections - BofA expects AMD to exceed consensus in both Q2 and Q3 earnings, forecasting revenues of $7.5 billion and $8.5 billion, respectively [7]. - For the full year 2025, BofA projects AMD's revenue to reach $33 billion and earnings per share of $4.10, both surpassing current Wall Street estimates [7]. Group 3: Market Opportunities and Drivers - Potential resumption of AI chip shipments to China in the second half of the year could contribute up to $1 billion in sales in 2025 and as much as $2 billion by 2026 [4]. - AMD is benefiting from stronger-than-expected pricing for its MI355X chips, with units selling for over $20,000, exceeding the consensus estimate of $17,000 [5]. - Strong demand for cloud-related GPUs, improving year-over-year comparisons in the PC segment, and steady enterprise interest from companies like Hewlett Packard Enterprise and Texas Instruments are also positive drivers [5]. Group 4: Market Share Projections - AMD is projected to capture more than 30% of the global CPU market by 2026, up from just under 20% in 2023 [8]. - Its share of the competitive AI GPU space could grow to 4% to 5%, supported by strategic shifts and manufacturing uncertainties at Intel [8]. Group 5: Analyst Ratings - Wall Street remains bullish on AMD stock, with Goldman Sachs reiterating a 'Buy' rating with a $140 target, while HSBC upgraded AMD to 'Buy' with a $200 target [8][9]. - Citi maintained a 'Hold' but raised its target from $120 to $145, indicating improved expectations [9].

Core Viewpoint - BrightSpring Health Services, Inc. announced the pricing of a secondary offering of 14,000,000 shares at $21.75 per share, with proceeds going to the selling stockholders, including KKR affiliates and management members [1] Group 1: Offering Details - The offering is underwritten and will close on June 12, 2025, subject to customary closing conditions [1] - The KKR Selling Stockholder has granted underwriters a 30-day option to purchase an additional 2,100,000 shares [1] - No shares are being sold by BrightSpring itself in this offering [1] Group 2: Underwriters and Managers - Goldman Sachs & Co. LLC, BofA Securities, Jefferies, and Morgan Stanley & Co. LLC are the lead book-running managers for the offering [2] - KKR Capital Markets LLC is acting as the lead managing agent [2] - A number of other firms are participating as bookrunners and co-managers for the offering [2] Group 3: Registration and Compliance - A shelf registration statement was filed with the SEC on June 10, 2025, and became effective upon filing [3] - The offering will be made only by means of a prospectus supplement and accompanying prospectus [4]